Explore the vast range of titles available.

Chromitites or chromite mineralization of varying degrees has been discovered in the various ophiolites along the east–west trending Yarlung-Zangbo Suture Zone (YZSZ) in Tibet, China. The high-Cr variety dominates the Yarlung-Zangbo chromitites, with rare high-Al chromitites reported in the Zedang, Dongbo, and Purang ophiolites. Using empirical equations, the calculated parental magmas that formed the high-Cr YZSZ chromitites are similar to boninitic melts. 187Os/188Os ratios of chromites from the YZSZ chromitites range from 0.12525 to 0.12933, lower than the proposed present-day 187Os/188Os values for the primitive upper mantle. The TRD age variation of the YZSZ chromitites from late Neo-Proterozoic to early Triassic thus reflects that their parental magmas are derived from depleted mantle sources mixed with diachronous ancient mantle domains. The light Zn isotopic compositions of the YZSZ chromitites indicate that subducted materials (e.g., serpentinites and sediments) have contributed to the parental magma of the YZSZ chromitites. By compiling previously published data on mantle peridotites of the YZSZ ophiolites, we concluded that the YZSZ ophiolites may either have formed initially in an ultraslow-slow mid-ocean ridge environment and were then trapped in a supra-subduction zone environment, or have formed in an ultraslow-slow forearc spreading center in a supra-subduction zone environment. The Luobusa ophiolite hosting the largest chromite deposits is discriminated from the other ophiolites in the YZSZ by a thick dunitic transition zone. Previous theoretical modeling indicates that relative to olivine, only a small amount of cumulus chromites crystallize in cotectic volume ratios of around 100:1 to 100:2 of olivine to chromite, which means that large chromite bodies should always be accompanied by a significantly larger mass of dunites. Therefore, we concluded that a thick dunite transition zone or large masses of dunite of boninitic affinity is an indicator for chromitite prospecting in the future.

Super-resolution correlative light and electron microscopy (SR-CLEM) is a powerful approach for imaging specific molecules at the nanoscale in the context of the cellular ultrastructure. Epon epoxy resin embedding offers advantages for SR-CLEM, including ultrastructural preservation and high quality sectioning. However, Epon embedding eliminates fluorescence from most fluorescent proteins. We describe a photocontrollable fluorescent protein, mEosEM, that can survive Epon embedding after osmium tetroxide (OsO 4 ) treatment for improved SR-CLEM. mEosEM survives 1% OsO 4 treatment and Epon embedding for improved super-resolution correlative light and electron microscopy.

The Cretaceous/Paleogene (K/Pg) Chicxulub impact produced globally synchronous enrichments of highly siderophile elements (HSEs) and a pronounced decline in marine osmium isotope ratios (187Os/188Os), forming a key geochemical marker of the boundary. However, precise identification of the K/Pg boundary remains challenging in extensive pelagic regions dominated by deep‐sea red clay, where calcareous and/or siliceous microfossils are poorly preserved. Here we identify the K/Pg boundary in a pelagic clay sequence from piston core KR13‐02 PC05 recovered near Minamitorishima Island in the western Pacific Ocean using HSE concentrations and Os isotope stratigraphy, supported by ichthyolith biostratigraphy and magnetostratigraphy. A distinct Ir enrichment (up to ∼16 ppb) coincides with the most unradiogenic 187Os/188Os value (∼0.14) at ∼9.95 mbsf, defining a geochemical horizon consistent with the global signature of the Chicxulub impact. Polarity chrons spanning C29n–C30n and ichthyolith assemblages support the placement of the K/Pg boundary and provide a robust chronological framework. Above the boundary, 187Os/188Os ratios remain persistently unradiogenic over a stratigraphic interval corresponding to several hundred thousand years. This prolonged signal reflects the integrated effects of extremely low sedimentation rates, sediment reworking by bioturbation, and background extraterrestrial dust inputs. These results demonstrate that sedimentary Os isotope records in low‐accumulation pelagic clay do not necessarily represent a simple archive of contemporaneous seawater composition. Instead, depositional and diagenetic processes can substantially modify post‐impact isotopic signals. Our findings highlight the necessity of multi‐proxy chronological control and careful geochemical screening when reconstructing oceanic responses to the K/Pg impact on microfossil‐poor pelagic environments.

Platinum-based metallodrugs are the most widely used anticancer agents. Their reduced effectiveness after repeat dosing (resistance) constitutes a major clinical problem. We study a potent organo-osmium compound with improved activity over cisplatin and no cross-resistance in platinum-resistant cancers. This compound disrupts metabolism in A2780 human ovarian cancer cells, generating reactive oxygen species and damaging DNA. We identified mutations in complex I of the electron transport chain in A2780 cells and suggest that the osmium compound may exploit these mutations to exert a potent mechanism of action. Such activity increases selectivity toward cancer cells, given that normal-functioning cells can better adapt to drug-induced metabolic perturbations. Therefore, this report highlights a promising strategy to drive the future development of organometallic anticancer compounds. The organometallic “half-sandwich” compound [Os(η ⁶- p -cymene)(4-(2-pyridylazo)- N,N -dimethylaniline)I]PF ₆ is 49× more potent than the clinical drug cisplatin in the 809 cancer cell lines that we screened and is a candidate drug for cancer therapy. We investigate the mechanism of action of compound 1 in A2780 epithelial ovarian cancer cells. Whole-transcriptome sequencing identified three missense mutations in the mitochondrial genome of this cell line, coding for ND5, a subunit of complex I (NADH dehydrogenase) in the electron transport chain. ND5 is a proton pump, helping to maintain the coupling gradient in mitochondria. The identified mutations correspond to known protein variants (p.I257V, p.N447S, and p.L517P), not reported previously in epithelial ovarian cancer. Time-series RNA sequencing suggested that osmium-exposed A2780 cells undergo a metabolic shunt from glycolysis to oxidative phosphorylation, where defective machinery, associated with mutations in complex I, could enhance activity. Downstream events, measured by time-series reverse-phase protein microarrays, high-content imaging, and flow cytometry, showed a dramatic increase in mitochondrially produced reactive oxygen species (ROS) and subsequent DNA damage with up-regulation of ATM, p53, and p21 proteins. In contrast to platinum drugs, exposure to this organo-osmium compound does not cause significant apoptosis within a 72-h period, highlighting a different mechanism of action. Superoxide production in ovarian, lung, colon, breast, and prostate cancer cells exposed to three other structurally related organo-Os(II) compounds correlated with their antiproliferative activity. DNA damage caused indirectly, through selective ROS generation, may provide a more targeted approach to cancer therapy and a concept for next-generation metal-based anticancer drugs that combat platinum resistance.

Mauna Loa is one of the largest and most active volcanoes on Earth. The most recent eruption of Mauna Loa started on 27 November 2022, lasted for 13 days, and was preceded by the longest repose time of 38 years in its modern history. In this contribution, new trace- and highly siderophile-element (HSE: Os, Ir, Ru, Pt, Pd, Re) abundances, 187 Re- 187 Os, and 18 O/ 16 O data are reported for the 2022 lavas. These lavas have a limited range of MgO (6.2 ± 0.1 wt.%) and Ni (83 ± 2 µg/g), with a broader range of Re (0.3 to 1.3 ng/g) and consistent Os (0.031 to 0.080 ng/g) contents. They have 187 Os/ 188 Os ratios (0.1345 to 0.1385) which are, on average, more radiogenic than Mauna Loa picrites (0.1331 to 0.1349) and are similar in composition to more differentiated Mauna Loa tholeiite lavas (0.1340 to 0.1381). The oxygen isotope compositions of glassy samples are 5.35 ± 0.15‰ ( n  = 13) and span a range in δ 18 O of + 5.0 to + 5.5‰, with an average composition 0.2 to 0.3‰ lower than MORB. The δD value is − 81 ± 11‰ ( n  = 5) at very low (0.03 ± 0.015 wt.%) H 2 O concentrations. The 2022 Mauna Loa eruption is similar in terms of δ 18 O but contrasts in terms of 187 Os/ 188 Os variability, with the recent longer-lived eruptions on La Palma (Canary Islands; 85 days) in 2021 and on the Reykjanes Peninsula (Iceland) that began in 2021 and are still ongoing. Initial lavas were more fractionated for both the Canary Islands and Iceland eruptions, producing more radiogenic Os isotope compositions than later erupted products. The 2022 Mauna Loa eruption showed no such trends. The limited range in isotope compositions of the 2022 Mauna Loa lavas and their strongly fractioned HSE patterns reflect long-term storage, crystal fractionation, and assimilation of related basaltic volcanic edifice materials by the parent magma beneath the volcano prior to eruption triggering. Eruption of differentiated and homogeneous tholeiite lavas at the summit caldera and high on the volcano’s flank, with emplacement of accumulative picrites lower on the volcano, are consistent with neutral buoyancy arguments.

The innovation of iron production is often considered one of the greatest technological advances in human history. A reliable provenancing method for iron is instrumental for the reconstruction of economic, social and geo-political aspects of iron production and use in antiquity. Although the potential of osmium isotopes analysis for this purpose has been previously suggested, here we present for the first time the results of osmium isotope analysis of ores, bloom and metal obtained from a set of systematic, bloomery iron-smelting experiments, utilizing selected ores from the Southern Levant. The results show that the 187Os/188Os ratio is preserved from ore to metal, with no isotopic fractionation. In addition, enrichment/depletion of osmium content was observed in the transition from ore to metal and from ore to slag. This observation has potential significance for our ability to differentiate between the various processes and sheds light on the suitability of various production remains for this method, which emerges as a robust and promising tool for the provenancing of archaeological ferrous metals.

Membrane materials with osmium nanoparticles have been recently reported for bulk membranes and supported composite membrane systems. In the present paper, a catalytic material based on osmium dispersed in n–decanol (nD) or n–dodecanol (nDD) is presented, which also works as an emulsion membrane. The hydrogenation of p–nitrophenol (PNP) is carried out in a reaction and separation column in which an emulsion in the acid-receiving phase is dispersed in an osmium nanodispersion in n–alcohols. The variables of the PNP conversion process and p–aminophenol (PAP) transport are as follows: the nature of the membrane alcohol, the flow regime, the pH difference between the source and receiving phases and the number of operating cycles. The conversion results are in all cases better for nD than nDD. The counter-current flow regime is superior to the co-current flow. Increasing the pH difference between the source and receiving phases amplifies the process. The number of operating cycles is limited to five, after which the regeneration of the membrane dispersion is required. The apparent catalytic rate constant (kapp) of the new catalytic material based on the emulsion membrane with the nanodispersion of osmium nanoparticles (0.1 × 10−3 s−1 for n–dodecanol and 0.9 × 10−3 s−1 for n–decanol) is lower by an order of magnitude compared to those based on adsorption on catalysts from the platinum metal group. The advantage of the tested membrane catalytic material is that it extracts p–aminophenol in the acid-receiving phase.

(1) Background: Ruthenium and osmium complexes attract increasing interest as next generation anticancer drugs. Focusing on structure-activity-relationships of this class of compounds, we report on 17 different ruthenium(II) complexes and four promising osmium(II) analogues with cinnamic acid derivatives as O,S bidentate ligands. The aim of this study was to determine the anticancer activity and the ability to evade platin resistance mechanisms for these compounds. (2) Methods: Structural characterizations and stability determinations have been carried out with standard techniques, including NMR spectroscopy and X-ray crystallography. All complexes and single ligands have been tested for cytotoxic activity on two ovarian cancer cell lines (A2780, SKOV3) and their cisplatin-resistant isogenic cell cultures, a lung carcinoma cell line (A549) as well as selected compounds on three non-cancerous cell cultures in vitro. FACS analyses and histone γH2AX staining were carried out for cell cycle distribution and cell death or DNA damage analyses, respectively. (3) Results: IC50 values show promising results, specifically a high cancer selective cytotoxicity and evasion of resistance mechanisms for Ru(II) and Os(II) compounds. Histone γH2AX foci and FACS experiments validated the high cytotoxicity but revealed diminished DNA damage-inducing activity and an absence of cell cycle disturbance thus pointing to another mode of action. (4) Conclusion: Ru(II) and Os(II) compounds with O,S-bidentate ligands show high cytotoxicity without strong effects on DNA damage and cell cycle, and this seems to be the basis to circumvent resistance mechanisms and for the high cancer cell specificity.

We report the rational engineering of a remarkably stable yellow fluorescent protein (YFP), ‘hyperfolder YFP’ (hfYFP), that withstands chaotropic conditions that denature most biological structures within seconds, including superfolder green fluorescent protein (GFP). hfYFP contains no cysteines, is chloride insensitive and tolerates aldehyde and osmium tetroxide fixation better than common fluorescent proteins, enabling its use in expansion and electron microscopies. We solved crystal structures of hfYFP (to 1.7-Å resolution), a monomeric variant, monomeric hyperfolder YFP (1.6 Å) and an mGreenLantern mutant (1.2 Å), and then rationally engineered highly stable 405-nm-excitable GFPs, large Stokes shift (LSS) monomeric GFP (LSSmGFP) and LSSA12 from these structures. Lastly, we directly exploited the chemical stability of hfYFP and LSSmGFP by devising a fluorescence-assisted protein purification strategy enabling all steps of denaturing affinity chromatography to be visualized using ultraviolet or blue light. hfYFP and LSSmGFP represent a new generation of robustly stable fluorescent proteins developed for advanced biotechnological applications. The engineered hyperfolder YFP (hfYFP) and variants offer unprecedented chemical and thermal stability, making them versatile probes for microscopy as well as for challenging applications like correlative light and electron microscopy and expansion microscopy.

Catalytic anticancer metallodrugs active at low doses could minimize side-effects, introduce novel mechanisms of action that combat resistance and widen the spectrum of anticancer-drug activity. Here we use highly stable chiral half-sandwich organometallic Os(II) arene sulfonyl diamine complexes, [Os(arene)(TsDPEN)] (TsDPEN, N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine), to achieve a highly enantioselective reduction of pyruvate, a key intermediate in metabolic pathways. Reduction is shown both in aqueous model systems and in human cancer cells, with non-toxic concentrations of sodium formate used as a hydride source. The catalytic mechanism generates selectivity towards ovarian cancer cells versus non-cancerous fibroblasts (both ovarian and lung), which are commonly used as models of healthy proliferating cells. The formate precursor N-formylmethionine was explored as an alternative to formate in PC3 prostate cancer cells, which are known to overexpress a deformylase enzyme. Transfer-hydrogenation catalysts that generate reductive stress in cancer cells offer a new approach to cancer therapy.